Clinical Trial

Effects of the Contraceptive Implant in Women With Sickle Cell Disease

Study acronym: SCD CURE
Active, Not Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The objective of this study is to measure the acceptability and impact of the progestin implant on frequency of vaso-occlusive crises, quality of life, and hematologic parameters in women with SCD.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2023-02-06; most recent amendment 2026-06-11.
Status change: Recruiting → Active, Not Recruiting 2026-06-11
Status change: Not Yet Recruiting → Recruiting 2023-06-27
Trial Details
NCT Number NCT05730205
Lead Sponsor University of Pennsylvania
Conditions Sickle Cell Disease
Enrollment 22 participants
Start Date 2023-08-02
Primary Completion 2027-03 (estimated)
Study Completion 2027-03 (estimated)
Updated on ClinicalTrials.gov 2026-06-12